Allegra-D Oral Tablet, Extended Release 24 Hour 180-240Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Allegra-D: Oral tablet, extended release 24 hour (180-240mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_6886.JPG
Allegra-D 24Hr Tab
Sanofi-Aventis US LLC
Pill Identification: 308 AV 
Drug Image file DrugItem_14532.JPG
Fexofen/PSE 120-240mg 24Hr Tab
Dr. Reddy's Laboratories, Inc.
Pill Identification: RDY  |  572
Drug Image file DrugItem_15623.JPG
Allegra-D 24Hr Allergy & Cong
Chattem, Inc. is a wholly-owned subsidiary of Sanofi-Aventis
Pill Identification: 308AV 
Drug Image file DrugItem_15624.JPG
Allegra-D 24Hr Allergy & Cong
Chattem, Inc. is a wholly-owned subsidiary of Sanofi-Aventis
Pill Identification: 308AV 
Drug Image file DrugItem_15625.JPG
Allegra-D 24Hr Allergy & Cong
Chattem, Inc. is a wholly-owned subsidiary of Sanofi-Aventis
Pill Identification: 308AV 
Drug Image file DrugItem_16544.JPG
Allergy Relief D 24Hr ER Tab
CVS Pharmacy, Inc
Pill Identification: RDY  |  572
Drug Image file DrugItem_16545.JPG
Allergy Relief D 24Hr ER Tab
CVS Pharmacy, Inc
Pill Identification: RDY  |  572

What is this Medicine?

FEXOFENADINE; PSEUDOEPHEDRINE (fex oh FEN a deen; soo doe e FED rin) is an antihistamine and a decongestant. This medicine is used to treat or prevent symptoms of allergies.

In-Depth Information

Allegra-D 24 Hour 180mg-240mg Extended-Release Tablet

NDC: 000881095
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Allergic Rhinitis, Common Cold

Storage Information
Store at controlled room temperature (between 68 and 77 degrees F)
Allegra-D 24 Hour 180mg-240mg Extended-Release Tablet
Drug Image file DrugItem_6886.JPG
Sanofi-Aventis US LLC
Pill Identification: 308 AV 
Shape: round
Color: white
Daily Life Interactions for Allegra-D 24 Hour 180mg-240mg Extended-Release Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Allegra-D 24 Hour 180mg-240mg Extended-Release Tablet(Fexofenadine Hydrochloride)
Grapefruit juice and Fexofenadine Hydrochloride(Fexofenadine Hydrochloride)
Do not take Fexofenadine with fruit juices, such as Grapefruit juice. Taking Fexofenadine at the same time as Grapefruit juice may reduce the effectiveness of this allergy medication in some people. Fexofenadine should be taken with water.
Moderate Lifestyle Interaction
Caffeine-containing Foods/Beverages and Allegra-D 24 Hour 180mg-240mg Extended-Release Tablet(Pseudoephedrine Hydrochloride)
Caffeine-containing Foods/Beverages and Pseudoephedrine(Pseudoephedrine Hydrochloride)
Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Pseudoephedrine. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Pseudoephedrine may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Allegra-D

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.